- 83
- 0
- 约13.91万字
- 约 25页
- 2024-02-01 发布于山东
- 举报
Cardonaetal.WorldAllergyOrganizationJournal(2020)13:100472
/10.1016/j.waojou.2020.100472
POSITIONPAPER
WorldAllergyOrganizationAnaphylaxis
Guidance2020
abcd
VictoriaCardona*,IgnacioJ.Ansotegui,MotohiroEbisawa,YehiaEl-Gamal,
efgh
MontserratFernandezRivas,StanleyFineman,MarioGeller,AlexeiGonzalez-Estrada,
ijKl
PaulA.Greenberger,MarioSanchezBorges,GianenricoSenna,AzizSheikh,
mno,1p,1
LucianaKaseTanno,BernardY.Thong,PaulJ.TurnerandMargittaWorm
ABSTRACT
Anaphylaxisisthemostsevereclinicalpresentationofacutesystemicallergicreactions.The
occurrenceofanaphylaxishasincreasedinrecentyears,andsubsequently,thereisaneedto
continuedisseminatingknowledgeonthediagnosisandmanagement,soeveryhealthcarepro-
fessionalispreparedtodealwithsuchemergencies.Therationaleofthisupdatedposition
documentistheneedtokeepguidancealignedwiththecurrentstateoftheartofknowledgein
anaphylaxismanagement.TheWorldAllergyOrganization(WAO)anaphylaxisguidelineswere
publishedin2011,andthecurrentguidanceadoptstheirmajorindications,incorporatingsome
novelchanges.Intramuscularepinephrine(adrenaline)continuestobethefirst-linetreatmentfor
anaphylaxis.Nevertheless,itsuseremainssuboptimal.Afterananaphylaxisoccurrence,patients
shouldbereferredtoaspe
原创力文档

文档评论(0)